OSI PHARMACEUTICALS INC 4
4 · OSI PHARMACEUTICALS INC · Filed Dec 3, 2004
Insider Transaction Report
Form 4
GIBSON NEIL
VP & Chief Scientific Officer
Transactions
- Award
Common Stock
2004-11-19$58.16/sh+10$582→ 1,655 total - Exercise/Conversion
Common Stock
2004-12-01$21.55/sh+4,500$96,975→ 6,155 total - Sale
Common Stock
2004-12-01$48.30/sh−2,875$138,863→ 3,280 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-12-01−4,500→ 3,334 totalExercise: $21.55From: 2003-06-12Exp: 2012-06-11→ Common Stock (4,500 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months.
- [F3]The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.
- [F4]Includes only options with the same termination date.